Why Catapult Sports, Harvey Norman, Inghams, and Opthea shares are sinking today

These shares are having a tough time on hump day. Let's find out why.

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a decent gain. At the time of writing, the benchmark index is up 0.6% to 8,778.3 points.

Four ASX shares that have failed to follow the market higher today are listed below. Here's why they are falling:

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.

Image source: Getty Images

Catapult Sports Ltd (ASX: CAT)

The Catapult Sports share price is down 6.5% to $3.69. This is despite there being no news out of the sports technology company today. However, it is worth highlighting that Catapult's shares have been in fine form since the release of its results last month. This could have led to some investors taking a bit of profit off the table today.

Harvey Norman Holdings Ltd (ASX: HVN)

The Harvey Norman share price is down 4% to $4.31. This may have been driven by the release of a broker note out of Macquarie Group Ltd (ASX: MQG) on Wednesday. According to the note, the broker has downgraded Harvey Norman's shares to a neutral rating (from outperform) with a heavily reduced price target of $4.50 (from $6.60). Macquarie made the move on concerns that retailers could struggle in the current economic environment.

Inghams Group Ltd (ASX: ING)

The Inghams share price is down 5% to $1.96. Investors have been selling this poultry producer's shares after it was also downgraded by analysts at Macquarie. According to the note, the broker has downgraded its shares to an underperform rating (from neutral) with a $1.80 price target. Once again, this was due to concerns around consumer spending in the tough economic environment.

Opthea Ltd (ASX: OPT)

The Opthea share price is down 97% to 1.8 cents. This biotechnology company's shares have been smashed after returning from a suspension that lasted over a year. Opthea is shifting its focus from retinal diseases due to a clinical trial failure and is relaunching with a new strategy focused on OPT-302 as a potential treatment for lymphangioleiomyomatosis (LAM). LAM is a rare, chronic lung disease that primarily affects women. The company believes OPT-302 could have a role because the disease is associated with elevated VEGF-C and VEGF-D signalling, which OPT-302 is designed to inhibit. Opthea's executive chair, Dr Jeremy Levin, said: "Opthea is relaunching with a focused strategy centered on OPT-302 and a clear objective: to evaluate a differentiated, mechanism-driven therapeutic opportunity in LAM while leveraging the Company's substantial existing development, manufacturing and clinical infrastructure."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Catapult Sports and Macquarie Group. The Motley Fool Australia has positions in and has recommended Catapult Sports, Harvey Norman, and Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

Codan share price A dismayed kid dressed as a scientist stands with his back to a rocket crashed into the ground
Share Fallers

Xero shares crash to a 7-year low after a brutal sell-off

The decline has wiped out years of share price gains.

Read more »

Two miners at a mine site on their tablets, with mining machinery behind them.
Share Fallers

Why has the Mineral Resources share price fallen 12% this week?

It’s been another tough week for Mineral Resources shareholders.

Read more »

A man holds his hand to his chin with a furrowed brow, making an expression of puzzlement or confusion.
Share Fallers

Top 3 ASX 200 shares now below their 200-day moving average

Are these businesses still a buy?

Read more »

A young man clasps his hand to his head with a pained expression on his face and a laptop in front of him.
Share Fallers

What are the most shorted ASX shares on the market right now?

Two names, two opposite bear cases.

Read more »

An arrow crashes through the ground as a businessman watches on.
Share Fallers

Warning: Corporate Travel shares have crashed 80%. What on earth just happened?

An 80% crash has left investors asking what went so wrong.

Read more »

Stressed businessman sits in panic amid digital stock market financial background.
Share Fallers

The five worst-performing ASX 200 shares in August unmasked

Investors sent these five ASX shares crashing 17% to 23% in August. But why?

Read more »

Stressed businessman sits in panic amid digital stock market financial background.
Share Fallers

Why Megaport, Lendlease and JB Hi-Fi shares all crashed 14% to 15% this week

ASX investors punished Lendlease, Megaport, and JB Hi-Fi this week. But why?

Read more »

Woman checking out new laptops.
Consumer Staples & Discretionary Shares

Down 14% today: Are JB Hi-Fi shares now a bargain-bin buy?

Could JB's plunge mean a bargain buy?

Read more »